Dr Edwards trained at Guy’s Hospital, London and spent 14 years in hospital medicine and clinical research before joining the UK regulatory agency which used to be called the Medicines Control Agency. After 5 years there, he joined a global CRO, Parexel, for six years followed by 18 months at Johnson & Johnson as a deputy qualified person for pharmacovigilance.
For the last 13 years up until 2021, he was Principal Consultant in Pharmacovigilance at NDA Regulatory Science based in the UK.
In addition, he is Director of ISoP Secretariat Ltd and co-chairs the ISOP Medication Error Special Interest Group) and Chair of the UK Pharmaceutical Human Factors group.
Previously, he chaired the panel overseeing the ‘Drug Safety Surveillance’ module as part of Higher Medical Training for pharmaceutical medicine in the UK between January 2006 and 2012. He has been awarded a Fellowship with the International Society of Pharmacovigilance.
Currently he is Managing Director of his own consultancy Husoteria Ltd and has been co-leader of the DIA/ASA BRAP working group since 2020. More recently, he has been elected back onto the Board of ISOP and will be Vice-President on the Executive committee.